Therapeutic intervention in inflammatory diseases: A time and place for anti-adhesion therapy

M. Ursula Norman, Paul Kubes

Research output: Contribution to journalReview ArticleResearchpeer-review

16 Citations (Scopus)


The recruitment of leukocytes from the blood into tissue is central to the development and maintenance of the majority of inflammatory diseases. This multistep process requires a series of leukocyte-endothelial adhesive interactions, involving several families of adhesion molecules. Molecules that block these interactions have been targeted as potential therapeutic treatments for acute and chronic inflammatory diseases. However, many of the anti-adhesion therapy clinical trials have yielded disappointing outcomes. This review discusses some of the animal models that raise questions about the suitability of anti-adhesion therapy to treat certain inflammatory diseases. The authors suggest that it is crucial to understand the underlying mechanisms and timelines of leukocyte recruitment in each affected tissue and inflammatory disease to develop more effective anti-adhesion therapy.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
Issue number1
Publication statusPublished - Jan 2005
Externally publishedYes


  • Anti-selectin therapy
  • Integrins
  • Leukocyte recruitment

Cite this